Opportunity Assessment
Manage and track optimization opportunities
| ID | Type | Description | Vendor | Est. Value | Confidence | Status | Assigned To | Created | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||
| No opportunities match your filters. | ||||||||||
Showing - of opportunities
New
4 | $312K
OPP-2024-004
High
Renegotiate AmerisourceBergen contract
Renewal
$76K
OPP-2024-007
Med
Add specialty products to Baxter program
Product
$45K
In Analysis
12 | $620K
OPP-2024-003
Med
Expand Pfizer rebate to oncology
Product
$87K
ER
OPP-2024-005
Med
New Medline surgical supplies program
New
$65K
SJ
Recommended
8 | $480K
OPP-2024-001
High
Upgrade Cardinal Health to Platinum
Tier
$125K
SJ
Approved
6 | $340K
OPP-2024-002
High
Add 12 customers to McKesson
Customer
$98K
MC
In Progress
3 | $180K
OPP-2024-006
Low
Consolidate J&J Q4 purchases
Consolidation
$54K
MC
Pipeline visualization will show opportunity flow and conversion metrics
| ID | Type | Description | Vendor | Realized Value | Outcome | Closed Date |
|---|---|---|---|---|---|---|
| OPP-2024-021 | Tier Upgrade | Abbott tier upgrade to Gold | Abbott Laboratories | $145,000 | Realized | Oct 28 |
| OPP-2024-019 | Customer Exp | Expand customer base for Merck vaccines | Merck | $89,000 | Realized | Oct 15 |
| OPP-2024-017 | Renewal | Renewed Baxter contract with improved terms | Baxter International | $112,000 | Realized | Oct 5 |
| OPP-2024-015 | New Contract | New program with BD - Not pursued | Becton Dickinson | $0 | Dismissed | Sep 28 |
Total Realized Value (YTD): $1,847,000
Success Rate: 78% (23 of 29 opportunities)
- Type
- Vendor
- Est. Value
- Confidence
- Assigned To
- Created
- Status